Cargando…

Multigene Panel Testing in a Large Cohort of Adults With Epilepsy: Diagnostic Yield and Clinically Actionable Genetic Findings

BACKGROUND AND OBJECTIVES: Although genetic testing among children with epilepsy has demonstrated clinical utility and become a part of routine testing, studies in adults are limited. This study reports the diagnostic yield of genetic testing in adults with epilepsy. METHODS: Unrelated individuals a...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKnight, Dianalee, Bristow, Sara L., Truty, Rebecca M., Morales, Ana, Stetler, Molly, Westbrook, M. Jody, Robinson, Kristina, Riethmaier, Darlene, Borlot, Felippe, Kellogg, Marissa, Hwang, Sean T., Berg, Anne, Aradhya, Swaroop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678910/ https://www.ncbi.nlm.nih.gov/pubmed/34926809 http://dx.doi.org/10.1212/NXG.0000000000000650

Ejemplares similares

Elucidating clinical phenotypic variability associated with the polyT tract and TG repeats in CFTR
por: Nykamp, Keith, et al.
Publicado: (2021)

Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders
por: Winder, Thomas L., et al.
Publicado: (2020)

Value of genetic testing for pediatric epilepsy: Driving earlier diagnosis of ceroid lipofuscinosis type 2 Batten disease
por: Leal‐Pardinas, Fernanda, et al.
Publicado: (2022)

Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy
por: Truty, Rebecca, et al.
Publicado: (2019)

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
por: Leduc-Pessah, Heather, et al.
Publicado: (2022)

SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals
por: Bowen, B. Monica, et al.
Publicado: (2021)

Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation
por: Nascimento, Fábio A., et al.
Publicado: (2015)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Molecular evolution of dentin phosphoprotein among toothed and toothless animals
por: McKnight, Dianalee A, et al.
Publicado: (2009)

High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders
por: Stosser, Mary Beth, et al.
Publicado: (2018)

Telehealth for Children With Epilepsy Is Effective and Reduces Anxiety Independent of Healthcare Setting
por: Klotz, Kerstin Alexandra, et al.
Publicado: (2021)

Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing
por: Chen, Elaine, et al.
Publicado: (2023)

Clinical experience with multigene carrier panels in the reproductive setting
por: Terhaar, Catherine, et al.
Publicado: (2018)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders
por: Schuermans, Nika, et al.
Publicado: (2023)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
por: Coughlin, Sarah E., et al.
Publicado: (2022)

Jeffrey’s insights: Jeffrey Modell Foundation’s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment
por: Quinn, Jessica, et al.
Publicado: (2020)

Prevalence and properties of intragenic copy-number variation in Mendelian disease genes
por: Truty, Rebecca, et al.
Publicado: (2018)

Systematic use of phenotype evidence in clinical genetic testing reduces the frequency of variants of uncertain significance
por: Johnson, Britt, et al.
Publicado: (2022)

The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint
por: Xin, Ling, et al.
Publicado: (2017)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition
por: Tedaldi, Gianluca, et al.
Publicado: (2019)

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients
por: Park, Jihye, et al.
Publicado: (2019)

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
por: Lin, Xiaozeng, et al.
Publicado: (2022)

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population
por: Nindra, Udit, et al.
Publicado: (2023)

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
por: Wong, Edward S Y, et al.
Publicado: (2016)

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition
por: Martin-Morales, Lorena, et al.
Publicado: (2018)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
por: Tedaldi, Gianluca, et al.
Publicado: (2020)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1b3u9cj7idej6vo43gtnalupuj